Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe C Ornstein

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Hospice & Palliative Care|January 4, 2025
Medical Professionals' Perceptions of and Experiences With Terminally Ill Orthodox Jewish PatientsMoshe C Ornstein, David Harris
JCO Oncology Practice|September 16, 2021
Clinical Review on the Management of Metastatic Renal Cell CarcinomaJennifer Tran, Moshe C Ornstein
Current Treatment Options in Oncology|July 4, 2023
Targeting HIF-2 Alpha in Renal Cell CarcinomaRamsha Ahmed, Moshe C Ornstein
Expert Review of Anticancer Therapy|May 5, 2016
The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinomaMoshe C Ornstein, Brian I Rini
JCO Oncology Practice|February 12, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study ApproachLaura S Wood, Moshe C Ornstein
International Journal of Hematology|January 6, 2012
Combination strategies in myelodysplastic syndromesMoshe C Ornstein, Mikkael A Sekeres
Current Oncology (Toronto, Ont.)|December 23, 2021
Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell CarcinomaScott J Dawsey, Moshe C Ornstein
Kidney Cancer (Clifton, Va.)|October 19, 2018
Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic ReviewMoshe C Ornstein, Jorge A Garcia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Pharmacokinetically Guided Dosing of Oral Drugs: True Precision Oncology?Moshe C Ornstein, Brian I Rini
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment ApproachesMoshe C Ornstein, Thomas E Hutson
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Hospice & Palliative Care|January 4, 2025
Medical Professionals' Perceptions of and Experiences With Terminally Ill Orthodox Jewish PatientsMoshe C Ornstein, David Harris
JCO Oncology Practice|September 16, 2021
Clinical Review on the Management of Metastatic Renal Cell CarcinomaJennifer Tran, Moshe C Ornstein
Current Treatment Options in Oncology|July 4, 2023
Targeting HIF-2 Alpha in Renal Cell CarcinomaRamsha Ahmed, Moshe C Ornstein
Expert Review of Anticancer Therapy|May 5, 2016
The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinomaMoshe C Ornstein, Brian I Rini
JCO Oncology Practice|February 12, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study ApproachLaura S Wood, Moshe C Ornstein
International Journal of Hematology|January 6, 2012
Combination strategies in myelodysplastic syndromesMoshe C Ornstein, Mikkael A Sekeres
Current Oncology (Toronto, Ont.)|December 23, 2021
Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell CarcinomaScott J Dawsey, Moshe C Ornstein
Kidney Cancer (Clifton, Va.)|October 19, 2018
Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic ReviewMoshe C Ornstein, Jorge A Garcia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Pharmacokinetically Guided Dosing of Oral Drugs: True Precision Oncology?Moshe C Ornstein, Brian I Rini
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment ApproachesMoshe C Ornstein, Thomas E Hutson
Pageof 7